A month has gone by since the last earnings report for Toll Brothers (TOL). Shares have added about 9.8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading ...
Elanco Animal Health has begun a phased U.S. launch of Befrena, an anti-IL-31 monoclonal antibody injection for canine allergic and atopic dermatitis, following USDA approval in December 2025 and ...